Trial · NCT03783949
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Progression-free Survival | Standard Arm (Arm A) | 8.85 | 95% Confidence Interval 7.73 to 11.55 | months | |
| Progression-free Survival | Experimental Arms (Arm B&C) | 8.32 | 95% Confidence Interval 6.88 to 9.70 | months | |
| Progression-free Survival in BRCA Mutated Patients | Standard Arm (Arm A) | 11.78 | 95% Confidence Interval 7.30 to 17.37 | months | |
| Progression-free Survival in BRCA Mutated Patients | Experimental Arms (Arm B&C) | 7.98 | 95% Confidence Interval 6.09 to 11.05 | months | |
| Post-progression PFS (PFS2) | Standard Arm (Arm A) | 21.71 | 95% Confidence Interval 17.73 to 25.30 | months | |
| Post-progression PFS (PFS2) | Experimental Arms (Arm B&C) | 21.38 | 95% Confidence Interval 15.53 to 26.18 | months | |
| Time to First Subsequent Therapy (TFST) | Standard Arm (Arm A) | 9.38 | 95% Confidence Interval 8.09 to 12.47 | months | |
| Time to First Subsequent Therapy (TFST) | Experimental Arms (Arm B&C) | 8.75 | 95% Confidence Interval 7.40 to 10.07 | months | |
| Time to Second Subsequent Therapy (TSST) | Standard Arm (Arm A) | 17.73 | 95% Confidence Interval 14.28 to 21.61 | months | |
| Time to Second Subsequent Therapy (TSST) | Experimental Arms (Arm B&C) | 14.54 | 95% Confidence Interval 13.26 to 16.94 | months | |
| Progression-free Survival in Patients Without BRCA Mutation or With Unknown BRCA Status | Standard Arm (Arm A) | 7.83 | 95% Confidence Interval 6.58 to 11.38 | months | |
| Progression-free Survival in Patients Without BRCA Mutation or With Unknown BRCA Status | Experimental Arms (Arm B&C) | 8.49 | 95% Confidence Interval 6.71 to 10.49 | months | |
| Objective Response Rate (ORR) | Standard Arm (Arm A) | no response (SD/PD) | 21 | Participants | |
| Objective Response Rate (ORR) | Experimental Arms (Arm B&C) | no response (SD/PD) | 52 | Participants | |
| Objective Response Rate (ORR) | Standard Arm (Arm A) | response (PR/CR) | 17 | Participants | |
| Objective Response Rate (ORR) | Experimental Arms (Arm B&C) | response (PR/CR) | 27 | Participants | |
| Overall Survival (OS) | Standard Arm (Arm A) | 22.14 | 95% Confidence Interval 17.73 to 29.97 | months | |
| Overall Survival (OS) | Experimental Arms (Arm B&C) | 22.27 | 95% Confidence Interval 17.07 to 29.21 | months | |
| Progression-free Survival in Patients With Prior PARPi Treatment | Standard Arm (Arm A) | 7.40 | 95% Confidence Interval 5.63 to 8.85 | months | |
| Progression-free Survival in Patients With Prior PARPi Treatment | Experimental Arms (Arm B&C) | 6.09 | 95% Confidence Interval 2.76 to 7.76 | months |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03783949/results